// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Assessing visual acuity – test-retest repeatability and level of agreement between the electronic ETDRS chart (E-ETDRS), optokinetic nystagmus (OKN), and sweep VEP

Lily Yu-Li Chang - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

in vivo laser-mediated retinal ganglion cell optoporation using Kv1.1 conjugated gold nanoparticles

Ariel Wilson - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Dex-HEMA

Ocular and Orbital Manifestations of PHACES Syndrome: A case series.

Paul Huang - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The transcription factor SREBP-1 as a novel marker for sebaceous cell carcinoma of the eyelid

Paulina Garcia de Alba Graue - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

CD109: a novel marker for Ocular Surface Squamous Neoplasia differentiation

Prisca Raquel Bustamante - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

WITHDRAWN - Electroretinography evaluation in the Göttingen Minipig: An alternative animal model for ocular preclinical safety assessment

Christian Li - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Gentamicin

Human tau expression exerts beneficial effects on the mouse retinal function

Lea Rodriguez - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Assessment of the uniform field electroretinogram for mouse retinal ganglion cell functional analysis

Catherine Tsilfidis - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Receptors of intermediates of carbohydrate metabolism, GPR91 and GPR99, mediate axon growth.

Jean-Francois Bouchard - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

N/A

CI-1040

Thicknesses of the central retina, retina nerve fiber layer and choroid in SCUBA divers

Tamara Vrabec - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Cetirizine dihydrochloride - pseudoephedrine hydrochloride

Pathogenic Mechanisms Responsible for Stargardt Disease Associated with the N965S Missense Mutation in ABCA4

Laurie L Molday - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Molecular Characterization of Missense Mutations in Nucleotide Binding Domains of ABCA4 Associated with Stargardt Disease

Robert S Molday - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

IL-1 receptor modulators protect against oxygen-induced retinopathy

Colin Wayne Howe Cheng - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Pharmacological nonsense suppression therapy in the Rpe65-/- mouse model of Leber congenital amaurosis reverses the retinal deficits in vivo

Xia Wang - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

Amlexanox

Nogo-A inactivation promotes visual recovery and plasticity after retinal injury

Julius Baya Mdzomba - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Novel gene therapy for proliferative vitreoretinopathy.

Ting-Chia Wong - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Eye care utilization and its determinants in Canada: Cross-sectional findings from the Canadian Longitudinal Study on Aging

Rumaisa Aljied - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Unmet Eye Care Needs Among a Syrian Adult Refugee Population

Tarek Bin Yameen - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The prevalence and impact of eye disease in an urban homeless population

Collier Jiang - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Accuracy of a popular online symptom checker for ophthalmic diagnoses

Michael Nguyen - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved